Primary Site >> Liver Cancer
Gene >> NEK2
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. PMID: 19136513 |
Ref: Functional and topological properties in hepatocellular carcinoma transcriptome. PMID: 22539975 |
Ref: Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1. PMID: 24401611 Ref: Inhibition of Hec1 as a novel approach for treatment of primary liver cancer. PMID: 25038613 |
Ref: Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation. PMID: 26241688 Ref: Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway. PMID: 26337275 Ref: High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy. PMID: 26851035 Ref: NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma. PMID: 27349376 Ref: Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation. PMID: 27509921 |
Ref: Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression. PMID: 27925179 Ref: A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies. PMID: 28086821 Ref: NEK2 serves as a prognostic biomarker for hepatocellular carcinoma. PMID: 28101574 Ref: NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation. PMID: 28454295 Ref: Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis. PMID: 28759960 Ref: MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma. PMID: 28881785 Ref: Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets. PMID: 29025594 |
Ref: NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition. PMID: 29399700 Ref: NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection. PMID: 30145571 |